Description

Sinuspal (fenspiride) syrup 200 mg/100 ml. 100 ml. vial

Ingredients:

Each 5 ml of syrup contains 20 mg of fenspiride hydrochloride as the active ingredient. Other ingredients include sucrose, glycerol, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), citric acid monohydrate, sodium citrate, strawberry flavor, and purified water.

Dosage:

The recommended dosage for adults and children over 6 years old is 90 mg (15 ml) three times a day. For children aged 2 to 6 years, the dosage is 30 mg (5 ml) three times a day. It is important to follow the dosage instructions provided by the healthcare provider.

Indications:

Sinuspal syrup is indicated for the treatment of acute and chronic respiratory diseases associated with excessive mucus production. It helps to reduce cough and improve breathing by acting as a bronchodilator and mucolytic agent.

Contraindications:

Do not use Sinuspal syrup in patients with known hypersensitivity to fenspiride or any of the other ingredients. It is also contraindicated in patients with severe liver or kidney impairment.

Directions:

Shake the bottle well before use. The syrup can be taken with or without food. Use the provided measuring cup to ensure accurate dosage. Do not exceed the recommended dose.

Scientific Evidence:

Fenspiride, the active ingredient in Sinuspal syrup, has been studied for its efficacy in respiratory conditions. Research published in the journal “Pulmonary Pharmacology & Therapeutics” demonstrated that fenspiride has bronchodilator and anti-inflammatory properties, making it effective in the management of respiratory diseases.

Additional Information:

Sinuspal syrup is well-tolerated with a low incidence of side effects. Common side effects may include gastrointestinal disturbances and allergic reactions. It is always recommended to consult a healthcare professional before starting any new medication.

Fenspiride exerts its pharmacological effects by inhibiting the release of inflammatory mediators and modulating airway smooth muscle tone, leading to bronchodilation and improved airflow. Additionally, it has been shown to reduce the viscosity of mucus, making it easier to expectorate.

Comparative studies have shown that fenspiride is as effective as other bronchodilators and mucolytics in improving symptoms of respiratory conditions while having a favorable safety profile. Its dual mechanism of action sets it apart as a valuable option in the management of respiratory diseases.